Group Visits to Improve Pediatric ADHD Chronic Care Management by Bauer, Nerissa S. et al.
1Group Visits to Improve Pediatric ADHD Chronic Care Management 
Bauer NS, Szczepaniak D, Sullivan PD, Mooneyham G, Pottenger A, Johnson CS, Downs SM. 
Key Words:  Attention deficit disorder with hyperactivity; primary care; intervention studies; 
delivery of healthcare; group visit 
Short title:  Group visits to improve pediatric ADHD management 
Character Count: 49 (with spaces) 
Word Count 
Abstract: 249 
Manuscript: 4247 
Abbreviations: Attention-deficit hyperactivity disorder (ADHD) 
Financial Disclosure for All Authors: None of the authors have any financial relationships to 
disclose. 
Conflict of Interest for All Authors:  None of the authors have any conflicts of interest to 
disclose.   
_________________________________________________________________________________
 
This is the author's manuscript of the article published in final edited form as:
Bauer, N. S., Szczepaniak, D., Sullivan, P. D., Mooneyham, G., Pottenger, A., Johnson, C. S., & Downs, S. M. (2015). 
Group Visits to Improve Pediatric Attention-Deficit Hyperactivity Disorder Chronic Care Management. Journal of 
Developmental & Behavioral Pediatrics, 36(8), 553–561. https://doi.org/10.1097/DBP.0000000000000207
2ABSTRACT 
Objective: Children with ADHD may experience continued impairment at home and school 
even after medication initiation.  Group visits offer a way for pediatricians to provide more time 
to address ongoing needs.  A pilot study was undertaken to examine whether a group visit model 
improved ADHD management in the pediatric medical home. 
Method: Parents and children aged 6-18 with ADHD were recruited to and randomized to group 
visits or a usual care control.  Data included attendance at ADHD follow-up visits, parent-rated 
ADHD symptoms, adaptive functioning, and quality of life.  Longitudinal linear mixed models 
(continuous variables) and generalized linear mixed models (binary outcomes) were used to 
compare groups.  In our statistical models, child and family were random effects; study 
assignment was a fixed effect.  
Results:  Twenty families representing 29 children participated (Intervention: 9 parents/13 
children and control: 11 parents/16 children).  Aside from race, baseline characteristics of 
participants were similar.   None of the intervention families missed the expected 5 ADHD 
follow-up visits over 1 year; control families missed 1 or more visits over the same time period.  
Intervention families reported an improved level of adaptive functioning at 12-months compared 
to control (mean severity score: 3.7 vs. 4.4, p= 0.003).  All families reported greater limitations 
and poorer quality of life compared to national norms.  
Conclusion: Group visits in the pediatric medical home can improve adherence and preliminary 
results show a variety of improvements for the family. 
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INTRODUCTION 
Pediatric ADHD is the most common neurobehavioral disorder in childhood, with a prevalence 
of 5-11% (CDC, 2013).  The American Academy of Pediatrics (AAP)’s clinical practice 
guidelines advocate that pediatric providers should recognize ADHD as a chronic medical 
condition and manage it according to the principles of the chronic care model and the patient 
centered medical home1,2. One of the guiding principles of pediatric chronic care management is 
facilitating adherence to treatment and supporting the family unit.  Even though medications are 
efficacious and often lead to decreases in ADHD symptoms, families may continue to experience 
stress and children may have ongoing impairments in functioning at home and school3.  
Moreover, it is not uncommon for parents to question whether medications should be initiated in 
the first place or whether medications should continue to be used; they often receive conflicting 
messages from family and friends that may cause confusion4-7. Regardless of parental 
background and culture, parents desire more information about ADHD and the various treatment 
options that are available to support their children’s learning, behavior and overall functioning8-
10.  Pediatricians are poised to help parents weigh these decisions during the medical encounter; 
however, there is not enough time in the typical 20-minute visit to address these types of 
concerns or additional needs11. 
 
One potential solution to current care is the implementation of a group visit model.  While group 
visits in pediatrics are not new7,12,13, they have yet to be adopted as part of mainstream outpatient 
practice.  Group visits offer more time with a small group to facilitate an in-depth discussion.  
This model has been explored for well-child care12,13, prenatal care14, treatment of childhood 
	 4
disruptive behaviors15, and chronic care management for pediatric asthma16. However, there are 
no studies in the literature examining its use for pediatric ADHD chronic care management.  
Given the complexities surrounding initiation and continuation of medication, as well as the 
myriad of unmet family needs, the use of a group visit model to deliver chronic care 
management warranted further investigation.  We developed a curriculum designed to provide 
enhanced support to families dealing with ADHD and conducted a pilot study of using group 
visits in a busy pediatrics clinic.  Process and satisfaction data were collected from the 
pediatrician, staff and family, in addition to objective parent-reported measures to determine the 
impact the intervention had on ADHD symptoms, quality of life and adaptive functioning.  
Process and qualitative outcomes are reported in a separate paper. The focus of this paper is to 
report what effect group visits had on adherence to ADHD follow-up clinic visits and 
preliminary intervention effects. We hypothesized that families participating in group visits 
would improve adherence to current guidelines of routine ADHD follow-up visits every 3 
months and report improvements in overall functioning compared to control families. 
 
METHODS 
Study Population & Design 
Children aged 6 to 18 years of age with a known diagnosis of ADHD, who received routine 
medical care at a general pediatrics clinic in an academic medical center, along with their 
parents, were eligible to participate.   Stimulant naïve children were excluded due to the close 
monthly follow up required when first initiating and titrating medication.  Children with conduct 
disorder, autism or moderate to severe intellectual disability were also excluded.  Potential 
participants were identified by a physician referral or by self-referral.  For self-referral, an 
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interest flyer was provided to eligible families during ADHD follow-up visits.  Parents were 
informed about the study and, if interested, provided contact information.  A trained research 
assistant contacted the family to conduct additional study screening by telephone.  Siblings also 
meeting study criteria were allowed to participate.  Initially, the clinic chose to make three 
separate cohorts of intervention families based on the child’s age (6-9 years, 10-12 years and 13-
18 years). These age designations were proposed to facilitate pediatricians’ ability to address 
specific age-related parental concerns and child needs.  Eligible siblings were allocated to the 
group of the youngest child.  Prior to each initial group visit offered during the first three months 
of the study, families were given 3 weeks prior of to each of the scheduled group to enroll.  All 
names obtained by self-referral or telephone contact by research assistant were compiled.  Block 
randomization was done separately for each age group to keep siblings together and to balance 
the number of participants assigned to receive the group visit intervention or assigned as a 
control.   
 
Intervention 
Parents and children assigned to the intervention group were expected to attend five group visits, 
one every 3 months.  The frequency of the intervention would allow families to obtain the 
maximum number of prescriptions at each clinic visit while adhering to the AAP 
recommendation that ADHD follow up should occur at 3 to 6 month intervals17.  Rather than an 
individual 20-minute appointment, up to 6 families were scheduled for a 90-minute appointment 
in the late afternoon so to not require children to miss school. For the first 60 minutes, parents 
and children participated in separate but simultaneously run groups in adjacent rooms. The 
remaining time allowed for up to three 10-minute individual visits for each parent-child dyad for 
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each of the two general pediatricians who facilitated the group portion of the visits.  This 
individual time allowed for obtaining vital signs, monitoring of growth and refilling medications.   
Scheduling efforts were made to ensure groups were comprised of the same parent-child dyads 
throughout the study. Families who could not attend during their next quarterly visit were able to 
attend the same session another month.  When only 1 or 2 families could attend a particular 
month, efforts were made to reschedule group to the next month to ensure sufficient families in 
attendance for optimal group dynamics.  In order to accommodate families’ schedules, the initial 
age designation became a secondary consideration to scheduling subsequent group visits to the 
clinic.  Moreover, pediatric facilitators were the same throughout the study (1 was a general 
pediatrician on faculty who saw a large majority of patients with ADHD in the practice; the other 
was a triple board resident). 
A behavioral pediatrician (NB) and clinical child psychologist (PS) developed a study-
specific group curriculum: one for parents and one for children.  Briefly, the overall objective of 
the curriculum was to engage parents and children in ADHD chronic care and empower 
participants to learn skills related to self-care, communication and collaboration to improve 
functioning in both the home and school settings.  Facilitator guides included a framework to 
help facilitators conduct in-depth discussions with small groups of participants rather than 
sharing information in a lecture format.  The first session for parents and children was designed 
to help make participants comfortable talking and sharing in group, using a combination of “ice-
breakers” and probes to stimulate conversation about what ADHD is, goals for the group 
sessions, and group rules.  Parents were invited to share challenges of raising a child with ADHD 
and its impact on the family, as well as to reflect on their children’s strengths.  Children were 
supported as they completed child-friendly worksheets to reflect on their own strengths and 
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challenges.  They were encouraged to pick a behavior they wished to work on and begin to chart 
their progress using behavior charts provided during group.  Other sessions were designed to be 
delivered in any order.  Sessions for parents included: medications, educational advocacy, 
prevention of behavior issues, promoting positive parent-child relationships and handling 
common behavioral challenges.  Topics covered in the children’s curriculum included: 
identification of feelings and handling negative emotions, friendships and social skills, 
organizational strategies and handling school work, and a dedicated session to review past topics.  
At the end of each session, parents were given a set of “take home points” and were encouraged 
to try activities at home with their children.   
 
Measures 
Once children are started on medication for ADHD, chronic care management is initiated and 
requires that pediatricians schedule follow-up visits to review medication effects, overall 
functioning, monitor vital signs and growth, in addition to refilling prescriptions.  Our primary 
outcome of interest was determining the effect the intervention had on families’ adherence to 
routine ADHD care plan that included follow-up visits every 3 months.  Therefore, the total 
number of clinic visits for routine ADHD follow-up was examined over the study period 
(expected 5 over 12 months), comparing visit rates between intervention and control patients.  
Intervention families were required to sign in at the beginning of each group visit.  Therefore, 
these sheets were reconciled against electronic chart documentation. Clinic visits for control 
families were only captured by electronic chart documentation.  As the primary outcome of 
interest was whether families adhered to routine ADHD follow-up visits, electronic chart 
abstraction data regarding visit type (group or individual) and reason for visit were coded for 
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each subject.  Secondary outcomes of interest included measurement of the intervention’s impact 
on parent-reported ADHD symptoms, adaptive functioning and quality of life.  Participants 
completed each of the following scales at two time points: baseline and at study completion 12 
months later. 
 
NICHQ Vanderbilt ADHD Diagnostic Rating Scale-Follow Up (VADRS-F).  Parents 
were asked to complete the Vanderbilt ADHD Diagnostic Rating Scale-Follow up version at 
baseline.  This validated parent-report instrument is designed to measure ADHD symptoms and 
impairments related to performance18.  Parents rated 9 symptoms comprising the 
hyperactivity/impulsivity subscale and 9 symptoms comprising the inattention subscale on a 4-
point scale from “0” = not at all to “3” = very often. Total number of symptoms rated “2” or “3” 
are added for each subscale.  A set of 8 performance items is rated from 1 to 5 with greater 
numbers indicating impairments.  To meet diagnostic criteria for ADHD, scores of 6 or more and 
at least 1 performance score of at least 4 or higher are required.  Consideration of the ADHD 
subtype (primarily inattentive, primarily hyperactive-impulsive or combined) was also done 
based on scoring of the VADRS-F.  Data were re-coded so that if a child met diagnostic criteria 
for any subtype of ADHD based on clinical scoring of the VADRS-F was coded as “1” or not 
meeting criteria was coded as “0”. Parents were given the companion teacher-report form and 
instructed to provide the tool to their child’s teacher.    
 
Home Situations Questionnaire (HSQ).  The HSQ is a parent-reported measure designed 
to assess how various symptoms of ADHD affect children’s ability to function in the home 
environment and the extent to which ADHD symptoms disrupt daily activities19.  Parents rate 
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whether the child has difficulty following parental instructions regarding various tasks and if a 
problem, rate the severity of the situation on a 9-point scale (higher scores indicate more 
severity).   
 
Child Health Questionnaire-28 (CHQ-28).  Parents completed the CHQ-28, a validated 
quality of life instrument designed and normed for parents of children 5 to 18 years of age20.  
The CHQ-28 is completed by the parent and when scored results in two component summary 
scores (physical and psychosocial).  Two abbreviated versions (CHQ-50 and CHQ-28) were 
derived from the longer CHQ-87. The CHQ-28 demonstrates adequate discriminant validity and 
internal consistency for the 2 summary scales and significant test-retest reliability, particularly 
for the psychosocial summary scale21. The CHQ measures 14 unique physical and psychosocial 
concepts.  Responses can be analyzed separately and derive numerous profile scores or combined 
to derive CHQ summary scores, a physical and psychosocial score.  Higher scores indicate more 
favorable health and well-being. This scale includes normative data to make it possible to 
interpret a child health scale score or the average score for a group of children by comparing 
study sample scores to the general US population of children with similar health conditions, such 
as ADHD22.  
 
Parenting Sense of Confidence Scale (PSOC).  With this scale, parents rated their 
agreement to 16 statements on a 6-point Likert scale.  The instrument has two factors, 
satisfaction and efficacy23.   
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Attitudes, Satisfaction, Knowledge and Medication Experiences with ADHD Medicine 
Treatment (ASK-ME) Survey.  To measure parental knowledge and attitudes about stimulant 
treatment for ADHD, parents completed this survey comprised of 8 knowledge, 7 attitudinal and 
8 satisfaction items.  Scores are added within each subscale.  Higher scores are associated with 
more knowledge, more positive attitude and more satisfaction towards ADHD medication 
treatment24.  
 
Sample characteristics and demographics.  Parents were asked to report on their age, sex, 
highest level of education completed, marital status, race/ethnicity, and health literacy status 
(having 10 or more children’s books in the home, needing help understanding pamphlets, not 
feeling confident filling out medical forms)25-27.  Parents also reported the child’s age and sex. 
 
Statistical Analysis 
Sample characteristics and number of visits for routine ADHD follow-up were examined for the 
entire sample, differences between subjects at baseline and follow up compared using Fisher’s 
exact test (if cells had fewer than 5) or chi square.  For continuous variables (PSOC, CHQ-28, 
HSQ and ASK-ME), longitudinal linear mixed models were used to compare scores over time 
(baseline vs. one-year follow-up).  Child and family were random effects and group was a fixed 
effect.  The group by time interaction was included.  If the interaction term was significant at the 
0.10 level of significance, group effects were investigated at each time.  A variance components 
variance-covariance structure was assumed.  For binary variables (VADRS-F any diagnostic 
criteria met and combined criteria met), a generalized linear model approach (GEE) was used to 
test for the effect of group over time.  The binomial response probability distribution and the 
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logit link function were used.  When analyzing the CHQ-28 results, the population mean was 
obtained from the scoring manual and plotted on the graph to allow for easy comparison of the 
study sample average scores to the population mean by visual inspection; no formal statistical 
analysis was performed. The study protocol was submitted to our institutional review board and 
approved prior to the initiation of study procedures.   
 
RESULTS 
This pilot study started in September 2012 and the final data collection and group visit were 
completed in October 2013.  A total of 47 families met study eligibility requirements.  Of these, 
24 were from parents who completed an interest form and an additional 23 were from our clinic 
registry or pediatrician referral.  After initial telephone screening procedures to ensure study 
eligibility, parents and children were randomized into the intervention or control arms.  The final 
enrolled sample consisted of 9 parents and 13 children (3 of the 9 families included multiple 
siblings) in the intervention arm and 11 parents and 16 children (5 of the 11 families included 
multiple siblings) in the control arm.   
 The average age of child participants was 10 years (range between 6-14 years of age), 
with a majority of the children being male (intervention: 62% or 8/13 vs. control: 81% or 13/16; 
p=0.41).  All of the enrolled parents were female.  There were no significant differences among 
parents assigned to the intervention or control on the basis of age, race/ethnicity, marital status, 
highest level of education and health literacy status.  Eight of the children assigned to control and 
10 in the intervention had comorbid oppositional defiant disorder per DSM-IV criteria. One child 
in the intervention group had a known diagnosis of post-traumatic stress disorder and was being 
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seen by a child psychiatrist for that condition.  One child in the control group had Tourette 
syndrome.  See Table 1 for study sample characteristics.   
During the study period, 7 of 9 intervention families who attended the first group visit 
attended all subsequent sessions.  The reason for intervention discontinuation for one family was 
a move out of state due to parent employment.  The other family had significant psychosocial 
issues that prohibited participation. Intervention families attended all 5 expected routine follow 
up visits compared to an average of 3.4 visits for control families (p<0.01).  
 All the children were diagnosed with ADHD before the study started, using the AAP 
recommended guidelines. At the beginning of the study, the proportion of children treated but 
still meeting ADHD criteria, based on the VADRS-F, did not significantly differ between the 
groups (p=0.86).  At baseline, 6/13 (46%) of the children in the intervention arm and 11/16 
(69%) of the children in the control arm met DSM-IV clinical criteria.  Trends were examined on 
the basis of the proportion of children whose parent-reported symptoms worsened, improved or 
stayed the same.  While more intervention children continued to not meet criteria or showed 
improvement in parent reported symptoms (combined subtype at baseline and only 
hyperactive/impulsive subtype at follow-up) compared to control children, this finding was not 
significant (p=0.15).   
There was a possible group by visit interaction for the proportion of children meeting the 
combined ADHD criteria (p=0.10) so group differences were tested separately at each visit. At 
baseline, 31% (4/13) children in the intervention arm and 44% (7/16) in the control arm had at 
least 6 parent-reported symptoms on both the hyperactive and inattention scales of the VADRS-F 
(p=0.63).  At 1 year, 8% (1/13) children in the intervention arm and 56% (9/16) in the control 
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arm had at least than 6 parent-reported symptoms on both the hyperactive and inattention scales, 
thus meeting criteria for these ADHD subtypes (p=0.04).  See Table 2. 
 Children in the intervention group had improved adaptive functioning compared to 
controls as measured by the HSQ severity subscale. There was a significant group by time 
interaction (p=0.03).  The severity subscale score did not significantly change over time for 
controls (baseline mean = 4.7; 1-year follow-up mean = 4.4; p=0.8003). The severity score did 
significantly decrease in the intervention group (baseline mean = 5.5; 1-year follow-up mean = 
3.7; p=0.004).  There was not a significant group by time interaction for the Home Situations 
total score (p=0.20), nor was there a significant difference between the groups (p=0.11); 
however, the scores in both groups decreased over time (p=0.04). The mean total score within 
groups decreased from 8.7 to 7.6 for controls and 7.9 to 4.7 for families receiving the 
intervention.  However, the difference in decrease between the groups was not statistically 
significant (p = 0.20).  See Figure 1. 
 Results from CHQ-28 administration show that our entire study sample reported poorer 
quality of life, particularly within the psychosocial domain compared to the population mean.  
Study sample summary scores for physical functioning were not significantly different than the 
population mean.  See Figures 2a-2c.   
 There were no significant changes for overall quality of life (CHQ-28), parenting 
confidence or parental knowledge (PSOC), attitudes or satisfaction with medication experiences 
(ASK-ME) over the course of the study.  However, families in the intervention group had 
significant improvements in two subscales of the CHQ-28:  general health perceptions (p = 0.05) 
and improved quality of life related to family activities (p=0.001).  A trend towards improvement 
in the amount and performance of schoolwork and activities with friends was true for 
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intervention families over time (p = 0.07) as compared to the control group.  See Figures 2a-c.  
Overall quality of life as measured by the CHQ-28 continued to remain lower overall when 
compared to families with children without the disorder. 
 Almost all children were on medications through the study period and medication 
titration per accepted standard of care occurred during the individual time with the pediatrician 
after group visits for families assigned to the intervention.  Even though outside the scope of this 
paper, debriefing with families occurred throughout the study and at the last group session.  We 
learned one child had not been on medications at the start of the study but by the end the parent 
had become more comfortable with the decision and started medication on the basis of what she 
had learned and heard from other parents in the groups.  An additional parent ended up stopping 
her child’s medication by the end of the study due to the child expressing not wanting to be on it 
because of perceived side effects.  
 
DISCUSSION 
In our study, families who participated in group visits for ADHD follow-up completed more of 
the recommended clinic visits over the study period compared to families assigned to the control 
arm.  Our findings are encouraging given that prior to the intervention the no-show rate at the 
study clinic for ADHD follow-up visits was 30%, whereas the overall no-show rate for all other 
patients was 20% based on monitoring by the clinic for quality improvement efforts.  This was 
despite the fact that there existed a clinic policy that families bring children for an in-person 
examination on a quarterly basis to receive ADHD medication refills.  We encountered a few 
months when postponement was necessary until the following month so at least three or more 
families could attend.  Our families were willing to rearrange their schedules to be able to attend.  
	 15
As our clinic made the effort to schedule the same groups of parent-child dyads together for 
subsequent visits, it is likely that families made the effort to attend subsequent visits for ongoing 
support from those they connected with and felt comfortable talking to.  If families in the 
intervention arm had acute behavioral issues related to ADHD (for example, suspension), 
recommendations were made to schedule a separate individual visit to ensure adequate time to 
discuss this with the pediatrician and prevent too much of the group portion from being overly 
focused on a particular child.  This decision was also in part to ensure all families attending 
group would be seen in a timely fashion and thus not prolong the overall appointment. Parents in 
the intervention reported fewer ADHD symptoms and improved child functioning in the home.  
Even though all families in our study reported poorer quality of life compared to the overall 
population mean, findings of a positive change within two psychosocial subscales show early 
promise that this intervention may improve the support families receive, yet the mechanism is 
still unclear (more time with the pediatrician to provide education, normalization of experiences 
from group discussion or both).   
 Parenting a child with ADHD is often challenging and often leads to profound parenting 
stress and poor parent-child interactions28-30.  Moreover, needs change over the course of the 
condition as the child matures.  As with any pediatric chronic condition, it is imperative to 
engage both parents and children in the process of self-care to improve short and long-term 
outcomes21,31.  Our promising findings add support to the consideration of using a group visit 
model to improve adherence to recommended visits and medical home management of chronic 
conditions14,16,32,33. 
 Similar to past studies our sample reported ongoing clinically relevant limitations in 
psychosocial functioning, but no significant impairments in physical health compared to 
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normative populations34.  However, we found as intervention parents reported a reduction in 
ADHD symptoms, there was a corresponding parent-reported increase in children’s adaptive 
functioning in the home.  This finding is meaningful because even though combined treatment of 
ADHD with medication and behavioral strategies produces optimal outcomes related to 
functioning, access to such coordinated treatments in the community is unreliable and can also 
be difficult to access35,36.  At baseline, parents of children in both the intervention and control 
arms reported less than 6 ADHD symptoms overall.  This was not surprising as parents of 
children who are on medication for ADHD often end up reporting less ADHD symptoms over 
time; however, these children often have residual impairment3.  This was the case in our study 
sample as evidenced by the higher HSQ severity scores at baseline for both groups that measured 
adaptive functioning.  In addition, parents receiving the intervention also reported improved 
overall general health perceptions of their children.  One possible explanation for this is that 
intervention families perceived their child having improved general health from overall 
improvement in parent-child relationships, child functioning and quality of life.  
We have shown our intervention, delivered in the setting of a patient-centered medical 
home by two general pediatricians can be done despite the systems-level changes (i.e. 
scheduling) needed for its implementation.  Even though we did not test intervention delivery by 
other providers who might be co-located in the pediatric medical home, such as social workers, 
nurses or psychologists, it is an important future direction. While outside the scope of this 
current paper, another important consideration is the impact group visit models have on overall 
visit time, the amount of effort needed to schedule groups and provider and family satisfaction.  
Our intervention included active communication, support and shared decision making between 
the pediatrician and family integrated within chronic disease management, which is an important 
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factor in promoting treatment adherence and visit attendance37.  In addition, we collected 
measurement of meaningful outcomes for families, albeit preliminary.  It is important to not only 
include measurement of changes in ADHD symptoms via VADRS-F scores, but also on 
outcomes related to overall quality of life and adaptive functioning when assessing the impact of 
an intervention, especially if it necessitates a systems-level change38.  
 There are a few limitations to consider when interpreting the results of this study and 
limit the generalizability of our findings.  Our study sample was small and from one pediatric 
clinic.  The general pediatric clinic was based in an outpatient center affiliated with a pediatric 
hospital and academic center.  We reported national norms for the Child Health Questionnaire 
tool used to measure quality of life. While our sample was small and from one clinic, our sample 
of children with ADHD reported similar quality of life as compared to the population mean, 
which represents a larger and nationally normed sample. Moreover, even though residents are 
allowed to see patients on select days at this clinic, the lead pediatric facilitator had a large panel 
of ADHD patients.  All but 2 families included in the study were from her panel.  Additional 
study of this model is warranted in private practices or community practices to understand 
whether it can be done in other types of pediatric clinics.  Pediatric facilitators running the group 
intervention also saw the individual families assigned to usual care. This may have led to some 
carry over of content taught during group to individual families assigned to the control arm.  
However, what was missing for the control families was exposure to the group dynamic.  
Moreover, families who participated were likely highly motivated and/or had less schedule 
conflicts to attend the group visits when offered.  Clinics with the ability to offer multiple group 
visit appointments each month may be able to better accommodate families’ schedules.  We 
conducted multiple measures, and a few of our study findings were not statistically significant 
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but showed promising trends.  In this pilot study, we lacked the power to achieve statistical 
significance on all of these changes or adjust for multiple comparisons.  All data collection tools 
were based on parent-report, which are subject to social desirability and recall bias. However, 
while we sought to obtain teacher ratings on the VADRS-F per clinical care guidelines, so few 
were returned that we had incomplete data. However, this was a pilot study and more work is 
needed with a larger sample.   
  
CONCLUSION 
Group visits for ADHD chronic care management resulted in greater adherence of recommended 
ADHD follow-up visits to the clinic.  Parents participating in group visits reported greater 
improvements in child ADHD symptoms and functioning in the home.  Preliminary findings 
support the innovation of this intervention and its promise for improving family functioning with 
general pediatricians providing enhanced support to small groups of parents and children. 
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Table 1.  Study sample characteristics 
 
Child Characteristics Intervention (n=13) Control (n=16)  
 Mean SD Range Mean SD Range t-test p-value 
Age 10.4 2.4 6-14 10.6 2.1 8-14 0.84 
 
n % n % 
Fisher’s Exact 
Test 
p-value 
Male 8 61.5 13 81.3 0.41 
 
Parent Characteristics Intervention (n=9) Control (n=11)  
 Mean SD Range Mean SD Range t-test p-value 
Age 39.4 13.0 28-63 37.2 6.7 27-47 0.62 
 
n % n % 
Fisher’s Exact 
Test 
p-value 
Female 9 100.0 11 100.0 >0.99 
Race     
0.37   Caucasian 4 44.4 5 45.5   African American 3 33.3 6 54.5 
  Other 2 22.2 0 0.0 
Hispanic 2 22.2 0 0.0 0.19 
Marital Status     
0.94 
  Married 3 33.3 5 45.5 
  Divorced 1 11.1 1 9.1 
  Separated 0 0.0 1 9.1 
  Widowed 1 11.1 0 0.0 
  Never Married 4 44.4 4 36.4 
Some College 4 44.4 5 45.5 >0.99 
Have 10+ Children’s Books 9 100.0 8 72.7 0.22 
Need Help Understanding 
Pamphlets 
2 22.2 0 0.0 0.19 
Not Confident Filling Out 
Medical Forms 
1 11.1 0 0.0 0.45 
 
Table 2. Parent VADRS-F Scores at Baseline and Follow-up by group 
 
 Baseline Follow-up 
 No  Criteria Inattentive Only Hyperactive Only  Combined No  Criteria Inattentive Only Hyperactive Only  Combined
 
Control 5 (31.2%) 
2 
(12.5%) 
2 
(12.5%) 
7 
(43.8%) 
3 
(18.8%) 
4 
(25.0%) 
0 
(0.0%) 
9 
(56.2%) 
 
Intervention 7 (53.8%) 
2 
(15.4%) 
0 
(0.0%) 
4 
(30.8%) 
5 
(38.4%) 
4 
(30.8%) 
3 
(23.1%) 
1 
(7.7%) 
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 Figure 1. Improvements in adaptive functioning by parent report on the Home Situations Questionnaire as change in mean 
severity scores over time. 
 
A. 
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B. 
 
	
C.	
	
Figure 2. A. Changes in CHQ-28 psychosocial subscale scores for general health perceptions. B. Changes in CHQ-28 
psychosocial subscale scores for parent-rated family activities. C. Changes in CHQ-28 psychosocial subscale scores for 
limitations due to emotional difficulties. CHQ-28, Child Health Questionnaire 28. 
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Figure Legends. 
Figure 1.  Improvements in adaptive functioning by parent report on the Home Situations 
Questionnaire (HSQ) as change in mean severity scores over time. 
 
Figure 2a.  Changes in CHQ-28 psychosocial subscale scores for general health perceptions 
Figure 2b. Changes in CHQ-28 psychosocial subscale scores for parent-rated family activities  
 
Figure 2c. Changes in CHQ-28 psychosocial subscale scores for limitations due to emotional 
difficulties 
